share_log

HC Wainwright & Co. Maintains Buy on Arcadia Biosciences, Lowers Price Target to $10

Benzinga ·  Aug 28, 2023 18:26

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Arcadia Biosciences (NASDAQ:RKDA) with a Buy and lowers the price target from $15 to $10.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment